日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Comparative Cost Evaluation of Managed Entry Agreement Techniques Using Real-World Data from High-Cost Anticancer Drugs in Thailand

利用泰国高价抗癌药物的真实数据对管理准入协议技术进行成本比较评估

Owat, Piyapat; Sooksriwong, Chaoncin; Ratanabunjerdkul, Hataiwan; Phodha, Tuangrat

Diagnostic Potential of Oscillometry: A Population-based Approach

振荡法的诊断潜力:一种基于人群的方法

Veneroni, Chiara; Valach, Christoph; Wouters, Emiel F M; Gobbi, Alessandro; Dellacà, Raffaele L; Breyer, Marie-Kathrin; Hartl, Sylvia; Sunanta, Owat; Irvin, Charles G; Schiffers, Caspar; Pompilio, Pasquale Pio; Breyer-Kohansal, Robab

Reply to Salvi and Ghorpade: Z-Scores or Fixed Cutoff Values to Interpret Oscillometry: Opportunities from the LEAD Study

回复 Salvi 和 Ghorpade:Z 分数或固定临界值在解释振荡测量结果中的应用:LEAD 研究带来的机遇

Veneroni, Chiara; Valach, Christoph; Wouters, Emiel F M; Gobbi, Alessandro; Dellacà, Raffaele L; Breyer, Marie-Kathrin; Hartl, Sylvia; Sunanta, Owat; Irvin, Charles G; Schiffers, Caspar; Pompilio, Pasquale Pio; Breyer-Kohansal, Robab

Updated reference values for static lung volumes from a healthy population in Austria

奥地利健康人群静态肺容量的最新参考值

Mraz, Tobias; Asgari, Shervin; Karimi, Ahmad; Breyer, Marie-Kathrin; Hartl, Sylvia; Sunanta, Owat; Ofenheimer, Alina; Burghuber, Otto C; Zacharasiewicz, Angela; Lamprecht, Bernd; Schiffers, Caspar; Wouters, Emiel F M; Breyer-Kohansal, Robab

The national budget impact of managed entry agreement strategies match with high-cost drugs to maximise drug cost saving: a study protocol

国家预算对通过管理准入协议策略匹配高价药物以最大限度节省药品成本的影响:一项研究方案

Owat, Piyapat; Sooksriwong, Chaoncin; Ratanabunjerdkul, Hataiwan; Phodha, Tuangrat